158 related articles for article (PubMed ID: 36514145)
1. Monitoring of serum magnesium levels during long-term use of proton pump inhibitors in elderly japanese patients: is it really necessary or not?
Nakamura N; Yoneda K; Higo T; Kusumoto M
J Pharm Health Care Sci; 2022 Dec; 8(1):35. PubMed ID: 36514145
[TBL] [Abstract][Full Text] [Related]
2. Does long-term use of proton pump inhibitors cause hypomagnesaemia in Japanese outpatients?
Takeda Y; Doyama H; Tsuji K; Yamada S; Takemura K
BMJ Open Gastroenterol; 2014; 1(1):e000003. PubMed ID: 26462261
[TBL] [Abstract][Full Text] [Related]
3. Proton pump inhibitors not associated with hypomagnesemia, regardless of dose or concomitant diuretic use.
Chowdhry M; Shah K; Kemper S; Zekan D; Carter W; McJunkin B
J Gastroenterol Hepatol; 2018 Oct; 33(10):1717-1721. PubMed ID: 29514412
[TBL] [Abstract][Full Text] [Related]
4. Hypomagnesemia Among Outpatient Long-Term Proton Pump Inhibitor Users.
Biyik M; Solak Y; Ucar R; Cifci S; Tekis D; Polat İ; Göktepe MH; Sakiz D; Ataseven H; Demir A
Am J Ther; 2017; 24(1):e52-e55. PubMed ID: 25353358
[TBL] [Abstract][Full Text] [Related]
5. Proton pump inhibitor use for 12 months is not associated with changes in serum magnesium levels: a prospective open label comparative study.
Bahtiri E; Islami H; Hoxha R; Gashi A; Thaçi K; Karakulak Ç; Thaçi S; Qorraj Bytyqi H
Turk J Gastroenterol; 2017 Mar; 28(2):104-109. PubMed ID: 28082254
[TBL] [Abstract][Full Text] [Related]
6. Prevalence and risk factors of long-term proton pump inhibitors-associated hypomagnesemia: a cross-sectional study in hospitalized patients.
Recart DA; Ferraris A; Petriglieri CI; Alonso Serena M; Bonella MB; Posadas-Martinez ML
Intern Emerg Med; 2021 Apr; 16(3):711-717. PubMed ID: 33001349
[TBL] [Abstract][Full Text] [Related]
7. Is there a relationship between hypomagnesemia and proton-pump inhibitors in patients on chronic hemodialysis?
Mikolasevic I; Milic S; Stimac D; Zaputovic L; Lukenda Zanko V; Gulin T; Jakopcic I; Klaric D; Gulin M; Orlic L
Eur J Intern Med; 2016 May; 30():99-103. PubMed ID: 26905320
[TBL] [Abstract][Full Text] [Related]
8. Proton pump inhibitors and hypomagnesemia in the general population: a population-based cohort study.
Kieboom BC; Kiefte-de Jong JC; Eijgelsheim M; Franco OH; Kuipers EJ; Hofman A; Zietse R; Stricker BH; Hoorn EJ
Am J Kidney Dis; 2015 Nov; 66(5):775-82. PubMed ID: 26123862
[TBL] [Abstract][Full Text] [Related]
9. The relationship between proton pump inhibitor use and serum magnesium concentration among hemodialysis patients: a cross-sectional study.
Misra PS; Alam A; Lipman ML; Nessim SJ
BMC Nephrol; 2015 Aug; 16():136. PubMed ID: 26268579
[TBL] [Abstract][Full Text] [Related]
10. Proton Pump Inhibitors and Hypomagnesemia in Older Inpatients: An Observational Study.
Anna Vermeulen Windsant-van den Tweel AM; Derijks HJ; Gadiot NPPM; Keijsers CJPW
Sr Care Pharm; 2022 Dec; 37(12):623-630. PubMed ID: 36461136
[No Abstract] [Full Text] [Related]
11. Proton Pump Inhibitors and Serum Magnesium Levels in Patients With Torsades de Pointes.
Lazzerini PE; Bertolozzi I; Finizola F; Acampa M; Natale M; Vanni F; Fulceri R; Gamberucci A; Rossi M; Giabbani B; Caselli M; Lamberti I; Cevenini G; Laghi-Pasini F; Capecchi PL
Front Pharmacol; 2018; 9():363. PubMed ID: 29731714
[No Abstract] [Full Text] [Related]
12. The Risks and Benefits of Long-term Use of Proton Pump Inhibitors: Expert Review and Best Practice Advice From the American Gastroenterological Association.
Freedberg DE; Kim LS; Yang YX
Gastroenterology; 2017 Mar; 152(4):706-715. PubMed ID: 28257716
[TBL] [Abstract][Full Text] [Related]
13. Low Prevalence of Hypomagnesemia in Long-term Recipients of Proton Pump Inhibitors in a Managed Care Cohort.
Sharara AI; Chalhoub JM; Hammoud N; Harb AH; Sarkis FS; Hamadeh G
Clin Gastroenterol Hepatol; 2016 Feb; 14(2):317-21. PubMed ID: 26499924
[TBL] [Abstract][Full Text] [Related]
14. Effect of proton pump inhibitors on the development of hypomagnesemia induced by panitumumab.
Morii Y; Fujimoto S; Nakahara R; Okawa K; Senaha H; Fujiwara K; Tsubaki M; Matzno S; Takegami M; Shimomura K; Nishida S
Pharmazie; 2022 Feb; 77(2):81-84. PubMed ID: 35209968
[TBL] [Abstract][Full Text] [Related]
15. Adverse event profiles of hypomagnesemia caused by proton pump inhibitors using the Japanese Adverse Drug Event Report (JADER) Database.
Yamashiro K; Hosomi K; Yokoyama S; Ogata F; Nakamura T; Kawasaki N
Pharmazie; 2022 Sep; 77(7):243-247. PubMed ID: 36199184
[TBL] [Abstract][Full Text] [Related]
16. Is there a correlation between hypomagnesemia linked to long-term proton pump inhibitor use and the active agent?
Aydın Yoldemir Ş; Zeren Ozturk G; Akarsu M; Ozcan M
Wien Klin Wochenschr; 2022 Feb; 134(3-4):104-109. PubMed ID: 33751184
[TBL] [Abstract][Full Text] [Related]
17. Proton pump inhibitors use in hemodialysis patients and serum magnesium levels.
Erdem E
Int J Clin Exp Med; 2015; 8(11):21689-93. PubMed ID: 26885127
[TBL] [Abstract][Full Text] [Related]
18. Proton pump inhibitor-associated hypomagnesemia: what do FDA data tell us?
Luk CP; Parsons R; Lee YP; Hughes JD
Ann Pharmacother; 2013 Jun; 47(6):773-80. PubMed ID: 23632281
[TBL] [Abstract][Full Text] [Related]
19. Proton Pump Inhibitor Use, Hypomagnesemia and Risk of Cardiovascular Diseases: The Atherosclerosis Risk in Communities (ARIC) Study.
Rooney MR; Bell EJ; Alonso A; Pankow JS; Demmer RT; Rudser KD; Chen LY; Lutsey PL
J Clin Gastroenterol; 2021 Sep; 55(8):677-683. PubMed ID: 33471493
[TBL] [Abstract][Full Text] [Related]
20. Serum magnesium and proton-pump inhibitors use: a cross-sectional study.
Faulhaber GA; Ascoli BM; Lubini A; Mossmann M; Rossi G; Geib G; Furlanetto TW
Rev Assoc Med Bras (1992); 2013; 59(3):276-9. PubMed ID: 23680271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
